Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)

Explore clinical trials studying Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia). Study availability and eligibility vary by location and protocol.

3 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia) trial results

Recruiting

Linezolid Plus Standard of Care

NCT06958835

Conditions: Bacteremia, Bacterial Infections, Bacterial Infections and Mycoses, +10 more
Locations: Kantonsspital Aarau (KSA) Aarau, Canton of Aargau, Switzerland

St. Claraspital Basel, Canton of Basel-City, Switzerland

Inselspital Bern Bern, Canton of Bern, Switzerland

Hôpitaux universitaires de Genève (HUG) Geneva, Canton of Geneva, Switzerland

View Trial Details

Recruiting

Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus Bacteraemia

NCT06726395

Conditions: Bacteremia, Bacterial Infections, Bacterial Infections and Mycoses, +10 more
Locations: Skånes universitetssjukhus, Region Skåne Lund, Sweden

View Trial Details

Completed

A Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Subjects

NCT02439359

Conditions: Bacteremia, Bacterial Infections, Bacterial Infections and Mycoses, +7 more
Locations: Lenexa, Kansas, United States

Cf 301-105 Omaha, Nebraska, United States

View Trial Details

Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)

Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia) trial results

Linezolid Plus Standard of Care

Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus Bacteraemia

A Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Subjects

Related conditions